|
Wolfram Samlowski is a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN) and a member of the Research Developmental Therapeutics and Genitourinary Committees for US Oncology. His research interests include translational research and development of novel cancer immunotherapy agents, translational drug development as well as gene therapy. His clinical interests are in developing more effective treatments for advanced stages of melanoma and non-melanoma skin cancers (such as Merkel Cell Carcinoma), and renal cancer. == Career == Samlowski joined Comprehensive Cancer Centers of Nevada in 2011 as a medical oncologist and a member of the Research Developmental Therapeutics and Genitourinary Committees for US Oncology.〔http://www.cccnevada.com/our-physicians/medical-oncologists/wolfram-samlowski-m-d/〕 He has been a Clinical Professor of Medicine at the University of Nevada School of Medicine since 2007. He was the Chief, Section of Melanoma, Renal Cancer and Immunotherapy as well as a Professor in the Oncology Department at the Nevada Cancer Institute in Las Vegas, Nevada, from 2007 to 2011. Samlowski served as the Director of Translational Research, Multidisciplinary Melanoma Program at Huntsman Cancer Institute in Salt Lake City, Utah from 2000 to 2007. During his tenure at University of Utah (1981–2007), Samlowski held many positions including various faculty appointments with the Hematology/Oncology program (1981–1997), Director, Cancer Immunotherapy Program (1987–2007) and Professor, Division of Oncology (1997–2007). Samlowski earned his medical degree from Ohio State University in 1978, completed his internal medicine residency at Wayne State University in Detroit, Michigan, and his clinical fellowship in hematology/oncology at the University of Utah, Salt Lake City, Utah. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Wolfram Samlowski」の詳細全文を読む スポンサード リンク
|